Retail Earnings On Deck… And Alphabet About To Breakout? 8/18/25
CNBC's "Fast Money"
00:00
Market Movements: Novo Nordisk and Alphabet
This chapter explores the significant stock surge of Novo Nordisk following FDA approval for Rogovi, the first GLP-1 drug for a specific indication, alongside its strategic partnership with GoodRx. It also forecasts optimistic trends for Alphabet's stock amidst shifting investor sentiments and competitive dynamics in the pharmaceutical sector.
Transcript
Play full episode
